Callicida Kendu 500 mg/g ointment
Spain
Table of Contents
Package leaflet: Information for the user
Introduction
Package leaflet: information for the user
Callicida Kendu 500 mg/g ointment
Salicylic acid
Read the entire leaflet carefully before you start using this medicine, because it contains important information for you.
Follow exactly the instructions for using this medicine provided in this leaflet or those given by your doctor or pharmacist.
- Keep this leaflet, as you may need to read it again.
- If you need advice or more information, consult your pharmacist.
- If you experience any adverse effects, consult your doctor or pharmacist, even if these adverse effects are not listed in this leaflet.
- You should consult a doctor if you worsen or do not improve after 4-6 days.
Contents of the leaflet
- What Callicida Kendu is and what it is used for
- What you need to know before using Callicida Kendu
- How to use Callicida Kendu
- Possible adverse effects
- How to store Callicida Kendu
- Contents of the pack and other information
1. What Callicida Kendu is and what it is used for
It is a medicine containing salicylic acid at high concentrations, which has keratolytic properties, that is, it produces softening and subsequent destruction of the skin's stratum corneum.
Callicida Kendu is indicated for the removal of corns, calluses, or plantar warts, in adults and children over 14 years of age.
2. What you need to know before using Callicida Kendu
Do not use Callicida Kendu
- If you are allergic to salicylic acid, salicylates, or any of the other ingredients of this medicine (listed in section 6).
- If you have peripheral circulation problems.
- If you are diabetic.
- On the face, near the eyes, on mucous membranes (such as the genitals), or on other skin lesions different from those indicated in section 1.
- On red, inflamed, or irritated areas.
- In children under 2 years of age.
Warnings and precautions
Consult your doctor or pharmacist before starting to use Callicida Kendu.
- This medicine is for external use only (cutaneous use).
- Avoid contact with healthy skin.
- Even with careful application, complete or partial removal of the callus may cause some inflammatory reaction.
Consult your doctor or pharmacist if discomfort increases during treatment or persists. It is necessary to identify the cause of the condition and treat it accordingly (orthopedic measures, correction of pressure points, footwear modification).
- Prolonged use and/or large doses should be avoided, as this could lead to salicylate toxicity.
- Patients with severe renal impairment may experience reduced blood glucose levels (hypoglycemia).
Children
This medicine is contraindicated in children under 2 years of age. Use in children aged 2 to 14 years should only be carried out under medical supervision.
Use of Callicida Kendu with other medicines
Inform your doctor or pharmacist if you are using, have recently used, or might need to use any other medicines.
Do not use together with other products on the same area, such as: other keratolytic agents, abrasive soaps, benzoyl peroxide, resorcinol, sulfur, tretinoin, or preparations containing alcohol.
Pregnancy, breastfeeding, and fertility
If you are pregnant, breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medicine.
You should not use Callicida Kendu during pregnancy, except for short-term treatment of a small skin area.
Oral forms (e.g., tablets) of this class of medicines may cause adverse effects on the fetus. It is unknown whether the same risks apply to Callicida Kendu when used on the skin.
Driving and using machines
No effects have been reported that could affect the ability to drive vehicles or operate machinery.
3. How to use Callicida Kendu
Follow exactly the instructions for use provided in this leaflet or those given by your doctor or pharmacist. If in doubt, ask your doctor or pharmacist.
For topical use only.
Adults and children over 14 years of age: Apply a small amount of Callicida Kendu, sufficient to cover the corn, callus, or wart you wish to remove, once daily at bedtime. After approximately 6 days, the corn should begin to detach on its own or with the aid of washing or soaking in warm water.
If necessary, the treatment may be repeated, leaving a rest period of at least 5 days between treatments.
If the treatment is not effective after 4–6 days, or if symptoms worsen or persist, consult your doctor, who will reassess whether further measures are needed.
Do not use Callicida Kendu for more than 7 consecutive days.
Instructions for use:
For topical use.
After application, the area may be covered with gauze or a plaster.
Use in children
Do not use in children aged 2 to 14 years without consulting a doctor.
If you use more Callicida Kendu than you should
Due to the route of administration of this medicine (topical use), intoxication is unlikely.
In case of accidental contact with eyes or mucous membranes, rinse thoroughly with plenty of water.
Overdose or ingestion may cause symptoms of systemic salicylate toxicity.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service at telephone number: 91 562 04 20, indicating the medicine and amount taken (or go to a medical center).
If you forget to use Callicida Kendu
Do not use a double dose to make up for missed doses.
If you have any further questions about the use of this medicine, ask your doctor or pharmacist.
4. Possible adverse effects
Like all medicines, Callicida Kendu can cause adverse effects, although not everybody will experience them.
When applying the product, the following may occur: irritation, burning, and itching, even dermatitis (inflammation of the skin) and local ulceration. In these cases, it is recommended to temporarily discontinue treatment until the irritation subsides. When resuming treatment, special care must be taken to ensure that the ointment comes into contact only with the callus.
If the ointment is applied to open lesions, excessive erythema (redness) and skin desquamation may occur; other possible adverse effects include: scarring due to treatment.
Allergic reactions may also occur.
If you experience any adverse effects, consult your doctor or pharmacist, even if they are adverse effects not listed in this leaflet.
5. Storage of Callicida Kendu
No special storage conditions are required.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date stated on the packaging after EXP. The expiry date is the last day of the month indicated.
Medicines should not be disposed of via wastewater or household waste. Dispose of unused containers and medicines at the SIGRE Point located at your pharmacy. If you have any doubts, ask your pharmacist how to dispose of containers and medicines you no longer need. This will help protect the environment.
6. Contents of the container and other information
Composition of Callicida Kendu 500 mg/g ointment
- The active substance is Salicylic acid. Each gram of ointment contains 500 mg of salicylic acid (50 %).
- The other components (excipients) are: white filamentous paraffin and paraffin oil.
Nature of the product and contents of the container
Callicida Kendu is a homogeneous white ointment, smooth to the touch, without lumps or aggregates.
It is presented in aluminum tubes containing 10 g of ointment.
Marketing Authorization Holder and Manufacturer
Laboratorios Urgo S.L. - C/Florida, 29
20120 HERNANI (Guipúzcoa)
Spain
Date of the most recent review of this summary: October 2024.
Detailed and up-to-date information on this medicinal product is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/